- No Data
English
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
The attosecond level ultra short laser pulse provides a powerful method for detecting and imaging ultra short processes, such as the motion of electrons in atoms and molecules.Although ultra short laser pulses can be generated, generating ultra short and high-energy pulses is a continuous challenge. In order to expand the photon energy, photon flux, and continuous bandwidth of isolated attosecond ...
Recently, Emerson, the global leader in industrial automation, launched the all-new Branson ™ The GLX-1 laser welding machine, with its outstanding flexibility and innovative technology, accurately meets the urgent market demand for connecting small, complex or delicate plastic components. Its compact volume and modular design make it easy to integrate into the ISO-8 cleanroom environment, while t...
Recently, American photonics giant Coherent and Japan's Faraday 1867 Holdings signed a Letter of Intent (LOI), with the goal of expanding the manufacturing scale of high-temperature superconducting (HTS) tapes to be widely used in large-scale deployment of nuclear fusion reactors, while also promoting the transformation of green energy. Coherent's excimer laser is expected to be more widely used i...
According to foreign media reports, scientists from the Physics Research Institute and the Institute of Physics and the Center for Quantum Science and Engineering at the Swiss Federal Institute of Technology Lausanne (EPFL) in Lausanne, Switzerland have made a new progress in the field of excitation science, developing a smaller and quieter laser system than previous products.Small laser system (I...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...